M. Shargorodsky

发表

Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta‐Analysis

Ryan A. Harris, G. Hitman, R. Clarke, 2018, Journal of the American Heart Association.

Circulating osteoprotegerin in postmenopausal osteoporotic women: marker of impaired glucose regulation or impaired bone metabolism

M. Shargorodsky, M. Mashavi, Miriam Menaged, 2017, Menopause.

Relation of Adiponectin to Glucose Tolerance Status, Adiposity, and Cardiovascular Risk Factor Load

M. Boaz, M. Shargorodsky, Z. Matas, 2011, Experimental diabetes research.

Relation of Arterial Properties to Left Ventricular Hypertrophy in Hypertensive Adults: Focus on Gender-Related Differences

M. Boaz, M. Shargorodsky, Z. Matas, 2010, Angiology.

Determinants of Left Ventricular Hypertrophy in Hypertensive Patients: Identification of High-Risk Patients by Metabolic, Vascular, and Inflammatory Risk Factors

M. Boaz, M. Shargorodsky, M. Peer, 2013, International Journal of Angiology.

Effect of metformin treatment on circulating osteoprotegerin in patients with nonalcoholic fatty liver disease

M. Shargorodsky, Elena Sofer, 2015, Hepatology International.

Effect of angiotensin II receptor blockers, candesartan, on osteoprotegerin level in hypertensive patients: Link between bone and RAAS

M. Shargorodsky, D. Gavish, H. Oz, 2015, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2003, American journal of hypertension.

BONE-FAT RELATIONSHIP IN POSTMENOPAUSAL WOMEN WITH HIP FRACTURES

M. Shargorodsky, Y. Lipovetzki, 2016 .

Bone remodelling markers in hypertensive patients with and without diabetes mellitus: link between bone and glucose metabolism

Z. Feldbrin, M. Shargorodsky, 2015, Diabetes/metabolism research and reviews.

The effect of vitamin D supplementation on plasma leptin/adiponectin ratio in diabetic individuals with different haptoglobin phenotypes

M. Shargorodsky, Z. Matas, A. Breslavsky, 2014 .

Reply to Letter to the Editor Re “Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors” by A. Luckish et al.

M. Shargorodsky, 2009 .

Does a First‐Degree Family History of Diabetes Impact Placental Maternal and Fetal Vascular Circulation and Inflammatory Response?

M. Shargorodsky, J. Bar, M. Kovo, 2017, The Journal of clinical endocrinology and metabolism.

Insulin Treatment Is Associated With Improved Fetal Placental Vascular Circulation in Obese and Non-obese Women With Gestational Diabetes Mellitus

M. Shargorodsky, J. Bar, L. Schreiber, 2019, Front. Endocrinol..

Elevated ferritin and circulating osteoprotegerin levels as independent predictors of hip fracture in postmenopausal women admitted for fragility fracture: time for new screening strategies?

Z. Feldbrin, G. Zandman-Goddard, M. Shargorodsky, 2017, Immunologic research.

Role of RAAS and adipokines in cardiovascular protection: effect of different doses of angiotensin II receptor blocker on adipokines level in hypertensive patients.

M. Shargorodsky, M. Mashavi, H. Oz, 2014, Journal of the American Society of Hypertension : JASH.

Effect of vitamin D supplementation on markers of vascular function

G. Hitman, R. Clarke, N. Forouhi, 2018 .

Osteopontin levels in plasma, muscles, and bone in patient with non-healing diabetic foot ulcers: A new player in wound healing process?

Z. Feldbrin, M. Shargorodsky, E. Omelchenko, 2018, Journal of diabetes and its complications.

Does Metformin Treatment Influence Bone Formation in Patients with Nonalcoholic Fatty Liver Disease?

M. Shargorodsky, D. Gavish, E. Soifer, 2015, Hormone and Metabolic Research.

Placental maternal and fetal vascular circulation in healthy non-obese and metabolically healthy obese pregnant women.

M. Shargorodsky, J. Bar, M. Kovo, 2017, Atherosclerosis.

The relationship between hypertensive disorders in pregnancy and placental maternal and fetal vascular circulation.

M. Shargorodsky, J. Bar, L. Schreiber, 2017, Journal of the American Society of Hypertension : JASH.

Pheochromocytoma: a disease with many faces.

R. Zimlichman,, M. Shargorodsky, 2002, The Israel Medical Association journal : IMAJ.

Elevated ferritin and circulating osteoprotegerin levels as independent predictors of hip fracture in postmenopausal women admitted for fragility fracture: time for new screening strategies?

Z. Feldbrin, M. Shargorodsky, G. Zandman-Goddard, 2016, Immunologic Research.

Increasing derangement of glucose homeostasis is associated with increased arterial stiffness in patients with diabetes, impaired fasting glucose and normal controls

M. Boaz, M. Shargorodsky, Z. Matas, 2010, Diabetes/metabolism research and reviews.

Primary aldosteronism: the most frequent form of secondary hypertension?

R. Zimlichman,, M. Shargorodsky, 2002, The Israel Medical Association journal : IMAJ.

Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.

M. Boaz, M. Shargorodsky, Z. Matas, 2007, The American journal of cardiology.

Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?

M. Boaz, M. Shargorodsky, Z. Matas, 2012, Cardiovascular Diabetology.

The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity

M. Boaz, R. Zimlichman,, M. Shargorodsky, 2006, International Journal of Obesity.

Diabetes and menopause aggravate age-dependent deterioration in arterial stiffness

M. Shargorodsky, M. Mashavi, Y. Shapiro, 2014, Menopause.

Arterial Elasticity in Cardiovascular Disease: Focus on Hypertension, Metabolic Syndrome and Diabetes

R. Zimlichman,, M. Shargorodsky, R. Cernes, 2008 .

Arterial elasticity in cardiovascular disease: focus on hypertension, metabolic syndrome and diabetes.

R. Zimlichman,, M. Shargorodsky, R. Cernes, 2008, Advances in cardiology.

Prolonged treatment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential hypertension.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2002, American journal of hypertension.

High dose treatment with angiotensin II receptor blocker in patients with hypertension: differential effect of tissue protection versus blood pressure lowering.

M. Boaz, R. Zimlichman,, M. Shargorodsky, 2008, Atherosclerosis.

Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?

M. Boaz, M. Shargorodsky, Z. Matas, 2009, Diabetes/metabolism research and reviews.

Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus.

R. Zimlichman,, M. Shargorodsky, Z. Matas, 2003, American journal of hypertension.

Does adiponectin level explain the atherogenic properties of Hp 2-2 phenotype in type 2 diabetic patients?

M. Boaz, M. Shargorodsky, Z. Matas, 2013, Atherosclerosis.

P 1: Do adiponectin levels explain the atherogenic properties of Hp 2-2 phenotype in type 2 diabetic patients?

M. Boaz, M. Shargorodsky, Z. Matas, 2012 .

Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?

M. Boaz, M. Shargorodsky, Z. Matas, 2009, International Journal of Obesity.

Effects of long-term risedronate treatment on serum ferritin levels in postmenopausal women with osteoporosis: the impact of cardiovascular risk factor load

Z. Feldbrin, M. Shargorodsky, A. Luckish, 2016, Menopause.

The association between the renin–angiotensin–aldosterone system and arterial stiffness in young healthy subjects

M. Boaz, M. Shargorodsky, Z. Matas, 2008, Clinical endocrinology.

Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health

M. Shargorodsky, D. Gavish, Alla Lukich, 2014, Cardiovascular Diabetology.

Open Access Research

R. Zimlichman,, M. Bakovic, A. Duncan, 2022 .

Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients.

M. Boaz, M. Shargorodsky, Z. Matas, 2013, Clinical nutrition.

Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2001, American journal of hypertension.

Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women.

M. Boaz, M. Shargorodsky, Z. Matas, 2009, Atherosclerosis.

Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial.

M. Boaz, M. Shargorodsky, Z. Matas, 2011, Metabolism: clinical and experimental.

Impact of Co-Morbid Mental Illness on the Diagnosis and Management of Patients Hospitalized for Medical Conditions in a General Hospital

M. Shargorodsky, G. Bar, I Briskman, 2012, International journal of psychiatry in medicine.

Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system: Reliability, repeatability, and establishment of normal values for healthy European population--the seven European sites study (SESS).

G. McVeigh, M. Boaz, R. Zimlichman,, 2005, American journal of hypertension.

Long-term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2006, Thyroid : official journal of the American Thyroid Association.

Effect of short- and long-term diabetes control on in-hospital and one year mortality rates in hospitalized patients with diabetic foot.

Z. Feldbrin, G. Zandman-Goddard, M. Shargorodsky, 2018, European journal of internal medicine.

[The harmful potential of herbal therapy].

R. Zimlichman,, M. Shargorodsky, 1994, Harefuah.

Vascular Impact of Metabolic Syndrome in Subjects with Normal Weight, Overweight, or Obesity: Is Normal Weight Sufficient for Vascular Health?

M. Shargorodsky, 2015, Journal of the American College of Nutrition.

The role of ferritin and adiponectin as predictors of cartilage damage assessed by arthroscopy in patients with symptomatic knee osteoarthritis.

Z. Feldbrin, D. Lakstein, G. Zandman-Goddard, 2018, Best practice & research. Clinical rheumatology.

Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients.

M. Boaz, M. Shargorodsky, Z. Matas, 2008, Atherosclerosis.

Adiponectin as an Independent Predictor of Left Ventricular Hypertrophy in Nondiabetic Patients With Hypertension

M. Shargorodsky, Z. Matas, D. Harpaz, 2015, Angiology.

Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease.

M. Shargorodsky, D. Gavish, E. Omelchenko, 2014, Journal of the American Society of Hypertension : JASH.

Treatment of hypertension with thiazides: benefit or damage-effect of low- and high-dose thiazide diuretics on arterial elasticity and metabolic parameters in hypertensive patients with and without glucose intolerance.

M. Boaz, R. Zimlichman,, M. Shargorodsky, 2007, Journal of the cardiometabolic syndrome.

Effect of Long-Term L-Arginine Supplementation on Arterial Compliance and Metabolic Parameters in Patients with Multiple Cardiovascular risk Factors: Randomized, Placebo-Controlled Study.

M. Boaz, R. Zimlichman,, M. Shargorodsky, 2010, Journal of cardiovascular pharmacology.

Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors.

M. Shargorodsky, Z. Matas, R. Cernes, 2008, Bone.

Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2002, The Israel Medical Association journal : IMAJ.

Weight loss induced by nutritional and exercise intervention decreases arterial stiffness in obese subjects.

M. Shargorodsky, Z. Matas, I. Goldberg, 2009, Clinical nutrition.

Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta‐Analysis

G. Hitman, R. Clarke, N. Forouhi, 2018, Journal of the American Heart Association.

Syddansk Universitet Effect of Vitamin D Supplementation on Markers of Vascular Function

N. Forouhi, F. Mose, I. Barchetta, 2018 .

Effect of long‐term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2‐year follow‐up study

M. Boaz, R. Zimlichman,, M. Shargorodsky, 2007, Diabetic medicine : a journal of the British Diabetic Association.